IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 118 filers reported holding IMMUNOVANT INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,027,750 | +350.7% | 1,225,000 | +122.7% | 2.74% | +369.7% |
| Q2 2023 | $10,433,500 | +146850.7% | 550,000 | +37.5% | 0.58% | +22.9% |
| Q4 2022 | $7,100 | -99.9% | 400,000 | +18.7% | 0.48% | +295.8% |
| Q1 2021 | $5,406,000 | -92.5% | 337,048 | -78.4% | 0.12% | -93.0% |
| Q4 2020 | $72,193,000 | +25.3% | 1,562,952 | -4.6% | 1.72% | -22.5% |
| Q3 2020 | $57,639,000 | – | 1,637,951 | – | 2.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |